These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Bone sarcomas: experience of an orthopedic oncology unit in the treatment of 180 consecutive cases, 1988-1995 (Part II)]. Bickels J; Kollender Y; Nirkin A; Isakov J; Mozes M; Merimsky O; Cohen I; Ben Harush M; Noyman Y; Meller I Harefuah; 1998 Mar; 134(5):378-81. PubMed ID: 10909556 [No Abstract] [Full Text] [Related]
23. Use of chemotherapy for patients with bone and soft-tissue sarcomas. Wesolowski R; Budd GT Cleve Clin J Med; 2010 Mar; 77 Suppl 1():S23-6. PubMed ID: 20179184 [TBL] [Abstract][Full Text] [Related]
24. [Bone tumors in children. Current trends in therapy]. Zucker JM; Pacquement H; Quintana E; Michon J; Doz F Pathol Biol (Paris); 1992 Nov; 39(9):948-9. PubMed ID: 1538946 [No Abstract] [Full Text] [Related]
25. The current management of malignant bone tumours: where do we go from here? Rosen G Med J Aust; 1988 Apr; 148(8):373-7. PubMed ID: 2833684 [No Abstract] [Full Text] [Related]
26. Evaluation of chemotherapy in children with metastatic Ewing's sarcoma and osteogenic sarcoma. Sutow WW; Vietti TJ; Fernbach DJ; Lane DM; Donaldson MH; Lonsdale D Cancer Chemother Rep; 1971 Feb; 55(1):67-78. PubMed ID: 5287340 [No Abstract] [Full Text] [Related]
28. Chemotherapy for Bone Sarcoma in Adults. Wagner MJ; Livingston JA; Patel SR; Benjamin RS J Oncol Pract; 2016 Mar; 12(3):208-16. PubMed ID: 26962160 [TBL] [Abstract][Full Text] [Related]
29. Appraising the current role of chemotherapy for the treatment of sarcoma. D'Adamo DR Semin Oncol; 2011 Oct; 38 Suppl 3():S19-29. PubMed ID: 22055968 [TBL] [Abstract][Full Text] [Related]
30. Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma. Drabko K; Raciborska A; Bilska K; Styczynski J; Ussowicz M; Choma M; Wojcik B; Zaucha-Prazmo A; Gorczynska E; Skoczen S; Wozniak W; Chybicka A; Wysocki M; Gozdzik J; Kowalczyk J Bone Marrow Transplant; 2012 Dec; 47(12):1530-4. PubMed ID: 22609883 [TBL] [Abstract][Full Text] [Related]
32. Bone mineral density deficits in pediatric patients treated for sarcoma. Kaste SC; Ahn H; Liu T; Liu W; Krasin MJ; Hudson MM; Spunt SL Pediatr Blood Cancer; 2008 May; 50(5):1032-8. PubMed ID: 17570705 [TBL] [Abstract][Full Text] [Related]
33. Phase II study of vinorelbine and continuous low doses cyclophosphamide in children and young adults with a relapsed or refractory malignant solid tumour: good tolerance profile and efficacy in rhabdomyosarcoma--a report from the Société Française des Cancers et leucémies de l'Enfant et de l'adolescent (SFCE). Minard-Colin V; Ichante JL; Nguyen L; Paci A; Orbach D; Bergeron C; Defachelles AS; André N; Corradini N; Schmitt C; Tabone MD; Blouin P; Sirvent N; Goma G; Geoerger B; Oberlin O Eur J Cancer; 2012 Oct; 48(15):2409-16. PubMed ID: 22633624 [TBL] [Abstract][Full Text] [Related]
34. A role for maintenance therapy in managing sarcoma. Ray-Coquard I; Le Cesne A Cancer Treat Rev; 2012 Aug; 38(5):368-78. PubMed ID: 21843915 [TBL] [Abstract][Full Text] [Related]
38. Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on the use of presurgical chemotherapy. Link MP Cancer Treat Res; 1993; 62():383-5. PubMed ID: 8096755 [No Abstract] [Full Text] [Related]
39. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Bond M; Bernstein ML; Pappo A; Schultz KR; Krailo M; Blaney SM; Adamson PC Pediatr Blood Cancer; 2008 Feb; 50(2):254-8. PubMed ID: 17262795 [TBL] [Abstract][Full Text] [Related]
40. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas. Holscher HC; Bloem JL; Nooy MA; Taminiau AH; Eulderink F; Hermans J AJR Am J Roentgenol; 1990 Apr; 154(4):763-9. PubMed ID: 2107673 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]